Dove Barbanel
Lawyers
Filters
Ionis Pharmaceuticals $500.3 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Jazz Pharmaceuticals $1 billion exchangeable senior notes offering
The exchangeable notes are due 2030
Siemens acquisition of Trayer Engineering
We advised Siemens on the transaction
CytomX Therapeutics $58.3 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Revolution Medicines $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
AssetMark strategic alliance with Morningstar and related acquisition of assets
We are advising AssetMark on the strategic alliance and acquisition of assets from Morningstar’s TAMP business
Bloom Energy $402.5 million green convertible notes offering
The 3% green convertible senior notes are due 2029
Doma take-private acquisition by Title Resources Group
We are advising Doma on the transaction
Intel $2.55 billion senior notes offering
The senior notes are due 2031, 2034 and 2054